Pediatrix Medical Group Inc (NYSE: MD) established initial surge of 3.41% at $22.11, as the Stock market unbolted on Thursday, before settling in for the price of $21.38 at the close. Taking a more long-term approach, MD posted a 52-week range of $11.84-$24.99.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 41.89%. Meanwhile, its Annual Earning per share during the time was 41.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 38.04%. This publicly-traded company’s shares outstanding now amounts to $85.83 million, simultaneously with a float of $84.39 million. The organization now has a market capitalization sitting at $1.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.17, while the 200-day Moving Average is $15.83.
Pediatrix Medical Group Inc (MD) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Pediatrix Medical Group Inc industry. Pediatrix Medical Group Inc’s current insider ownership accounts for 1.73%, in contrast to 95.48% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s Director sold 10,478 shares at the rate of 23.00, making the entire transaction reach 240,994 in total value, affecting insider ownership by 59,101.
Pediatrix Medical Group Inc (MD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.
Pediatrix Medical Group Inc’s EPS increase for this current 12-month fiscal period is 38.04% and is forecasted to reach 2.19 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.08% through the next 5 years, which can be compared against the 41.89% growth it accomplished over the previous five years trading on the market.
Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators
Let’s observe the current performance indicators for Pediatrix Medical Group Inc (MD). It’s Quick Ratio in the last reported quarter now stands at 1.83. Alongside those numbers, its PE Ratio stands at $11.67, and its Beta score is 0.73. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.99. Similarly, its price to free cash flow for trailing twelve months is now 6.95.
In the same vein, MD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.89, a figure that is expected to reach 0.54 in the next quarter, and analysts are predicting that it will be 2.19 at the market close of one year from today.
Technical Analysis of Pediatrix Medical Group Inc (MD)
Now, what If we examine the latest scores posted by [Pediatrix Medical Group Inc, MD]. During the last 5-days, its volume was better the volume of 0.8 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 12.60% While, its Average True Range was 46.27.
Raw Stochastic average of Pediatrix Medical Group Inc (MD) in the period of the previous 100 days is set at 78.10%, which indicates a major rise in contrast to 25.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.80 that was higher than 0.59 volatility it exhibited in the past 100-days period.
